FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness
Food and Drug Administration advisers unanimously recommended that the agency approve the first gene therapy for an inherited disease — a rare defect that causes blindness in children.(Image credit: Spark Therapeutics)
Source: NPR Health and Science - Category: Consumer Health News Authors: Rob Stein Source Type: news
More News: Blindness | Children | Food and Drug Administration (FDA) | Gene Therapy | Genetics | Health | Opthalmology | Science